Enhanced axillary assessment using contrast enhanced ultrasound (CEUS) before neo-adjuvant systemic therapy (NACT) in breast cancer patients identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant. (October 2020) - Cox, K.; Dineen, N.; Weeks, J.; Allen, D.; Akolekar, D.; Chalmers, R.; Burcombe, R.; Harper-Wynne, C.; Jyothirmayi, R.; Abson, C.